{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T06:07:38Z","timestamp":1747202858998,"version":"3.40.5"},"reference-count":6,"publisher":"Archives of Endocrinology and Metabolism","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,3,9]]},"DOI":"10.20945\/2359-3997000000453","type":"journal-article","created":{"date-parts":[[2022,3,11]],"date-time":"2022-03-11T14:22:44Z","timestamp":1647008564000},"page":"132-133","source":"Crossref","is-referenced-by-count":1,"title":["Use of unconventional antithyroid therapy in patients with thiamazole agranulocytosis in the context of the COVID-19 pandemic"],"prefix":"10.20945","volume":"66","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6861-5699","authenticated-orcid":false,"given":"Julio Alvarez","family":"Gamero","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6846-7630","authenticated-orcid":false,"given":"Victor Garc\u00eda","family":"Ruiz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2851-3727","authenticated-orcid":false,"given":"Jose Paz","family":"Ibarra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"8510","reference":[{"issue":"3","key":"key20220311092236_B1","first-page":"368","article-title":"Management of thyroid disorders during the COVID-19 outbreak: a position statement from the Thyroid Department of the Brazilian Society of Endocrinology and Metabolism (SBEM)","volume":"65","author":"Martins","year":"2021","unstructured":"Martins JRM, Villagelin DGP, Carvalho GA, Vaisman F, Teixeira PFS, Scheffel RS, et al. Management of thyroid disorders during the COVID-19 outbreak: a position statement from the Thyroid Department of the Brazilian Society of Endocrinology and Metabolism (SBEM). Arch Endocrinol Metab. 2021;65(3):368-75.","journal-title":"Arch Endocrinol Metab"},{"issue":"10","key":"key20220311092236_B2","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1089\/thy.2016.0229","article-title":"2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis","volume":"26","author":"Ross","year":"2016","unstructured":"Ross DS, Burch HB, Cooper DS, Greenlee MC, Laurberg P, Maia AL, et al. 2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis. Thyroid. 2016;26(10):1343-421.","journal-title":"Thyroid"},{"issue":"8","key":"key20220311092236_B3","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1056\/NEJMra1901214","article-title":"Drug Effects on the Thyroid","volume":"381","author":"Burch","year":"2019","unstructured":"Burch HB. Drug Effects on the Thyroid. N Engl J Med. 2019;381(8):749-61.","journal-title":"N Engl J Med"},{"issue":"4","key":"key20220311092236_B4","first-page":"254","article-title":"Use of lithium in the treatment of thyrotoxicosis","volume":"12","author":"Ng","year":"2006","unstructured":"Ng YW, Tiu SC, Choi KL, Chan FK, Choi CH, Kong PS, et al. Use of lithium in the treatment of thyrotoxicosis. Hong Kong Med J. 2006;12(4):254-9.","journal-title":"Hong Kong Med J"},{"key":"key20220311092236_B5","doi-asserted-by":"crossref","first-page":"694023","DOI":"10.1155\/2015\/694023","article-title":"Lithium Carbonate in the Treatment of Graves' Disease with ATD-Induced Hepatic Injury or Leukopenia","volume":"2015","author":"Zheng","year":"2015","unstructured":"Zheng R, Liu K, Chen K, Cao W, Cao L, Zhang H, et al. Lithium Carbonate in the Treatment of Graves' Disease with ATD-Induced Hepatic Injury or Leukopenia. Int J Endocrinol. 2015;2015:694023.","journal-title":"Int J Endocrinol"},{"key":"key20220311092236_B6","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/jca.21705","article-title":"Guidelines on the use of therapeutic apheresis in clinical practice \u2013 evidence-based approach from the writing committee of the American Society for Apheresis: the eighth special issue","volume":"34","author":"Padmanabhan","year":"2019","unstructured":"Padmanabhan A, Connelly-Smith L, Aqui N, Balogun RA, Klingel R, Meyer E, et al. Guidelines on the use of therapeutic apheresis in clinical practice \u2013 evidence-based approach from the writing committee of the American Society for Apheresis: the eighth special issue. J Clin Apher. 2019;34:171-354.","journal-title":"J Clin Apher"}],"container-title":["Archives of Endocrinology and Metabolism"],"original-title":[],"language":"en","deposited":{"date-parts":[[2022,3,11]],"date-time":"2022-03-11T14:22:49Z","timestamp":1647008569000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.aem-sbem.com\/article\/use-of-unconventional-antithyroid-therapy-in-patients-with-thiamazole-agranulocytosis-in-the-context-of-the-covid-19-pandemic\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022]]},"references-count":6,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,3,9]]}},"alternative-id":["10.20945\/2359-3997000000453"],"URL":"https:\/\/doi.org\/10.20945\/2359-3997000000453","relation":{},"ISSN":["2359-3997","2359-4292"],"issn-type":[{"type":"print","value":"2359-3997"},{"type":"electronic","value":"2359-4292"}],"subject":[],"published":{"date-parts":[[2022]]}}}